REMM-HIIT-CoV: REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05218083
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH), Vanderbilt University Medical Center (Other), Ohio State University (Other), University of Kentucky (Other), University of Alabama at Birmingham (Other)
120
2
40

Study Details

Study Description

Brief Summary

Multicenter, prospective, randomized controlled trial providing mobile health supported physical rehabilitation to 120 patients who have been critically ill with COVID-19 and who complete at least one exercise session.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT)
Phase 2

Detailed Description

REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) to improve recovery after Intensive Care Unit (ICU) discharge in patients with COVID-19 will evaluate the feasibility of clinical-, physiological- and patient-centered outcomes associated with a remotely monitored, mobile health-supported high intensity interval rehabilitation exercise training to improve the functional recovery of survivors who have experienced critical illness with COVID-19 and have been discharged home from the hospital.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2026
Anticipated Study Completion Date :
Mar 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: REmotely Monitored, Mobile health supported Multidomain Rehabilitation Program with HIIT

Patients will receive our REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training Program (REMM-HIIT) with iWatch/iPhone.

Behavioral: REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT)
REmotely Monitored, Mobile health-supported, High Intensity Interval Training consists of remotely monitored tailored, structured, progressive multidomain physical rehabilitation & personalized instruction & coaching. Patients complete 3 structured exercise sessions/week consisting of HIIT, strength, balance, and mobility exercises. Following warmup, patients increase workload at a heart rate corresponding to 95% VO2peak for 1-minute before returning to warm-up speed for 1-minute at a heart rate corresponding to 60% VO2peak. Strength includes functional strengthening exercises for lower extremities & general resistance exercises for major muscle groups. Balance incorporates static & dynamic exercises, including progressively narrowing base of support with eyes open or closed, reaching forward & backward starting within base of support & progressing to outside base of support. Mobility rehabilitation includes dynamic start/stop while walking and changing direction while walking.

No Intervention: Exercise education without personalized sessions or feedback

Patients will receive an exercise handout and iWatch/iPhone. Patients return home to exercise without personalized instruction and coaching.

Outcome Measures

Primary Outcome Measures

  1. Change in Cardiorespiratory fitness [Baseline to 3 months after hospital discharge]

    VO2P obtained during incremental 6 Minute Step Test

Secondary Outcome Measures

  1. Change in 6 minute walk distance [Baseline to 3 months after hospital discharge]

  2. Change in physical function measured by Short Physical Performance Battery (SPPB) score. [Baseline to 3 months after hospital discharge]

    Scores range from 0 (frailty) to 12 (robustness).

  3. Change in 30-sec sit to stand score [Baseline to 3 months after hospital discharge]

  4. Change in Fried Frailty Index Score [Baseline to 3 months after hospital discharge]

    Score ranges from 0 (not frail) to 5 (frail).

  5. Change in cognitive ability [Baseline to 3 months after hospital discharge]

    Measured by the Montreal Cognitive Assessment (MoCA) Test. Scores range from 0 to 30 with a lower score indicating more cognitive impairment.

  6. Change in cognitive ability [Baseline to 3 months after hospital discharge]

    Measured by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Score. Scores range from 40 to 160 with a lower score indicating more cognitive impairment.

  7. Change in cognitive ability [Baseline to 3 months after hospital discharge]

    Measured by the Hayling Scaled Score. Scores range from 1 (impaired) to 10 (very superior).

  8. Change in muscle mass obtained via MuscleSound [Baseline to 3 months after hospital discharge]

  9. Change in diet [Baseline to 3 months after hospital discharge]

    measured by the GLIM Criteria

  10. Change in EQ-5D-5L Score [Baseline to 6 months after hospital discharge]

    Scores range from -0.224 to 1, with 0, 1, and negative values corresponding to death, full health, and health states worse than death, respectively.

  11. Change in Duke Activity Status Index (DASI) Score [Baseline to 6 months after hospital discharge]

    DASI scores range from 0 to 58.2, with a higher score indicating higher functional capacity.

  12. Change in cognition from baseline to 3 months after hospital discharge [Baseline to 6 months after hospital discharge]

    Measured by PROMIS Cognitive function

  13. Change in fatigue from baseline to 3 months after hospital discharge [Baseline to 6 months after hospital discharge]

    Measured by PROMIS Fatigue questionnaire

  14. Change in physical function from baseline to 3 months after hospital discharge [Baseline to 6 months after hospital discharge]

    Measured by PROMIS Physical Function questionnaire

  15. Change in emotional support from baseline to 3 months after hospital discharge [Baseline to 6 months after hospital discharge]

    Measured by PROMIS emotional support questionnaire

  16. Change in social isolation from baseline to 3 months after hospital discharge [Baseline to 6 months after hospital discharge]

    Measured by PROMIS social isolation questionnaire

  17. Change in and Lawton Score [Baseline to 6 months after hospital discharge]

    Score ranges from 0 (very dependent) to 8 (high function, independent)

  18. Change in Katz Score [Baseline to 6 months after hospital discharge]

    Score ranges from 0 (very dependent) to 6 (independent)

  19. Change in quality of life [Baseline to 6 months after hospital discharge]

    Measured by Social determinants of health (SDOH) survey

  20. Change in IES-R [Baseline to 6 months after hospital discharge]

    Score ranges from 0 to 88, with a higher score indicating more affect of routine life stress, everyday traumas and acute stress

  21. Change in Hospital Anxiety and Depression Scale (HADS) Scores [Baseline to 6 months after hospital discharge]

    Scores ranges from 0 to 21 for both anxiety and depression, with a higher score indicating more symptoms of depression or anxiety

  22. Change in Posttraumatic Stress Disorder Checklist Score (PLC-5) [Baseline to 6 months after hospital discharge]

    Score ranges from 0 to 80, with a higher score indicating more PTSD symptoms.

  23. Change in diet [Baseline to 6 months after hospital discharge]

    measured by Diet History Questionnaire (DHQIII)

  24. Change in quality of life [Baseline to 6 months after hospital discharge]

    Measured by financial assessment based on the FACIT COST assessment

Other Outcome Measures

  1. Change in mitochondrial function [Baseline and 6 months post-hospital discharge]

    blood collection

  2. Change in biomarkers of inflammation [Baseline and 6 months post-hospital discharge]

    blood collection

  3. Change in biomarkers of aging [Baseline and 6 months post-hospital discharge]

    blood collection

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ICU admission and subsequent discharge for primary diagnosis of COVID-19 respiratory failure or infection requiring treatment with noninvasive ventilation (i.e., BiPap), High Flow Nasal Cannula O2, or Invasive mechanical ventilation for ≥ 48 hours with an ICU length of stay of ≥ 4 days.

  • Expected to be discharged directly home from the hospital (not to a skilled nursing facility, inpatient rehabilitation center, or long-term acute care hospital)

  • Able to ambulate with or without a gait aid prior to hospital discharge

  • Age ≥ 18 years

Exclusion Criteria:
  • Not ambulating independently prior to COVID-19 illness (use of a gait aid permitted)

  • Functional impairment resulting in inability to exercise at hospital discharge (including need for home oxygen requirement)

  • Inability or unwillingness to comply with the study requirements or unable or unwilling to follow coaching via mobile-health iPhone interaction

  • Any absolute contraindications to exercise, including but not limited to:

  • Recent (< 5 days) acute primary cardiac event

  • Unstable Angina

  • Uncontrolled dysrhythmias causing symptoms or hemodynamic compromise

  • Uncontrolled hypertension over 255 mmHg Systolic or 155 diastolic blood pressure

  • Symptomatic aortic stenosis

  • Uncontrolled symptomatic heart failure

  • Acute myocarditis or pericarditis

  • Suspected or known dissecting aneurysm

  • Any adverse changes during screening 6IST (i.e., persistent oxygen saturation drop below 88-90% or significant hypotension such as mean arterial blood pressure < 60 mmHg on 2 consecutive readings within 1 minute)

  • High risk for non-adherence as determined by screening evaluation

  • Anticipated hospital discharge before baseline study measures could be completed

  • Any condition, including cognitive impairment, that, in the judgment of the investigator, precludes participation because it could affect subject safety or ability of subject to complete the study

  • Pregnant

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Duke University
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Vanderbilt University Medical Center
  • Ohio State University
  • University of Kentucky
  • University of Alabama at Birmingham

Investigators

  • Principal Investigator: Paul Wischmeyer, MD, Duke Clinical Research Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05218083
Other Study ID Numbers:
  • Pro00109644
  • 1R01HD107103
First Posted:
Feb 1, 2022
Last Update Posted:
Aug 22, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2022